JYNT - NASDAQ

The Joint Corp.

JYNT·NASDAQ

$8.36

+0.54%

HealthcareMedical - Care Facilities

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$119.18M

EPS0.1900

P/E Ratio44.00

Earnings Date08/06/2026

jynt

Net Cash Provided by Financing Activities

Last Annual Value

-9.81M

3-Year CAGR

-214%

5-Year CAGR

-22%

10-Year CAGR

-6%

Adjust for Inflation

The Joint Corp. Competitors Analysis of Net Cash Provided by Financing Activities

JYNT · NASDAQ

Company	Net Cash Provided by Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
The Joint Corp. NASDAQ:JYNT	-9.81M	N/A	N/A	N/A
biote Corp. NASDAQ:BTMD	-43.55M	N/A	N/A	N/A
Inhibikase Therapeutics, Inc. NASDAQ:IKT	108.46M	134.6%	21.4%	N/A
CareCloud, Inc. NASDAQ:CCLD	-5.61M	N/A	N/A	N/A
DocGo Inc. NASDAQ:DCGO	-50.82M	N/A	N/A	N/A
TuHURA Biosciences, Inc. NASDAQ:HURA	19.93M	95.7%	23.1%	8.9%
Microbot Medical Inc. NASDAQ:MBOT	86.24M	136.0%	N/A	39.5%
Agenus Inc. NASDAQ:AGEN	122.84M	0.8%	-11.4%	N/A
Anika Therapeutics, Inc. NASDAQ:ANIK	-10.55M	N/A	N/A	N/A
Climb Bio, Inc. NASDAQ:CLYM	-21.00K	N/A	N/A	N/A
Cognition Therapeutics, Inc. NASDAQ:CGTX	36.57M	100.7%	-7.2%	N/A

The Joint Corp. Fair Value Envelope

JYNT · NASDAQ

Our analysis suggests that JYNT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $8.36, this represents a potential HIDDEN relative to our calculated worth for The Joint Corp..

HIDDEN

Intrinsic Value

Current Price: $8.36

Related Guides

Blog Categories

Continue your JYNT research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.